BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2458288)

  • 1. Anti-sense inhibition of tissue plasminogen activator production in differentiated F9 teratocarcinoma cells.
    Pecorino LT; Rickles RJ; Strickland S
    Dev Biol; 1988 Oct; 129(2):408-16. PubMed ID: 2458288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
    Wang SY; Gudas LJ
    J Cell Physiol; 1988 Aug; 136(2):305-11. PubMed ID: 2842348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells.
    Imada S; Yamaguchi H; Imada M
    Dev Biol; 1990 Oct; 141(2):426-30. PubMed ID: 1698671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation.
    Darrow AL; Rickles RJ; Pecorino LT; Strickland S
    Mol Cell Biol; 1990 Nov; 10(11):5883-93. PubMed ID: 2172788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
    Bjersing JL; Brorsson A; Heby O
    J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.
    Rickles RJ; Darrow AL; Strickland S
    J Biol Chem; 1988 Jan; 263(3):1563-9. PubMed ID: 2826484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
    Stoner CM; Gudas LJ
    Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective post-translational modification of collagen IV in a mutant F9 teratocarcinoma cell line is associated with delayed differentiation and growth arrest in response to retinoic acid.
    Wang SY; Roguska MA; Gudas LJ
    J Biol Chem; 1989 Sep; 264(26):15556-64. PubMed ID: 2549067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament proteins are constitutively expressed in F9 teratocarcinoma cells.
    Murtomäki S; Virtanen I; Liesi P
    Int J Dev Neurosci; 1999 Dec; 17(8):829-38. PubMed ID: 10593619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-kit protooncogene is stimulated by cAMP in differentiated F9 mouse teratocarcinoma cells.
    Nishina Y; Kobarai Y; Sumi T; Kosaka M; Nishikawa S; Nishimune Y
    Exp Cell Res; 1992 Feb; 198(2):352-6. PubMed ID: 1370268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators.
    Takeda M; Kosaka M; Nishina Y; Sawada K; Matsumoto K; Nishimune Y
    J Cell Biochem; 1992 Jul; 49(3):284-9. PubMed ID: 1644865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of PLC-gamma during the differentiation of mouse F9 teratocarcinoma cells.
    Lee YH; Lee HY; Ryu SH; Suh PG; Kim KW
    Cancer Lett; 1993 Feb; 68(2-3):237-42. PubMed ID: 8383002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic adenosine monophosphate-mediated induction of F9 teratocarcinoma differentiation in the absence of retinoic acid.
    Goldstein B; Rogelj S; Siegel S; Farmer SR; Niles RM
    J Cell Physiol; 1990 May; 143(2):205-12. PubMed ID: 1692026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and characterization of F9 teratocarcinoma stem cell mutants with altered responses to retinoic acid.
    Wang SY; Gudas LJ
    J Biol Chem; 1984 May; 259(9):5899-906. PubMed ID: 6325455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells.
    Wang SY; Gudas LJ
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5880-4. PubMed ID: 6310600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
    Khuri FR; Cho Y; Talmage DA
    Cell Growth Differ; 1996 May; 7(5):595-602. PubMed ID: 8732669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells.
    Wang SY; LaRosa GJ; Gudas LJ
    Dev Biol; 1985 Jan; 107(1):75-86. PubMed ID: 2981185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Levine RA; Campisi J; Wang SY; Gudas LJ
    Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transcriptional regulation of the abundance of mRNAs encoding alpha-tubulin and a 94,000-dalton protein in teratocarcinoma-derived stem cells versus differentiated cells.
    Howe CC; Lugg DK; Overton GC
    Mol Cell Biol; 1984 Nov; 4(11):2428-36. PubMed ID: 6513923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus E1A-mediated negative control of genes activated during F9 differentiation.
    Young KS; Weigel R; Hiebert S; Nevins JR
    Mol Cell Biol; 1989 Jul; 9(7):3109-13. PubMed ID: 2528683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.